Precision medicine for Parkinson’s disease: The subtyping challenge

Despite many pharmacological and surgical treatments addressing the symptoms of Parkinson’s disease, there are no approved treatments that slow disease progression. Genetic discoveries in the last 20 years have increased our understanding of the molecular contributors to Parkinson’s pathophysiology,...

Descripción completa

Detalles Bibliográficos
Autores principales: Frasier, Mark, Fiske, Brian K., Sherer, Todd B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751632/
https://www.ncbi.nlm.nih.gov/pubmed/36533178
http://dx.doi.org/10.3389/fnagi.2022.1064057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751632/
https://www.ncbi.nlm.nih.gov/pubmed/36533178
http://dx.doi.org/10.3389/fnagi.2022.1064057

Ejemplares similares